RDY
Dr. Reddy's Laboratories Ltd.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IN
$13.19
−0.53%Forward multiples
Based on analyst estimates
- P/E forward
- 34.64x
- P/E 2026E
- 29.35x
- P/E 2027E
- 22.15x
- P/E 2028E
- 18.12x
- P/S forward
- 3.86x
Trailing multiples
Trailing twelve months
- P/E TTM
- 31.40x
- PEG TTM
- 1.49x
- Price / book
- 2.72x
- Price / sales
- 3.13x
- Price / cash flow
- 25.41x
Enterprise value
- Enterprise value
- $10.9B
- EV / sales
- 3.11x
- EV / EBITDA
- 16.94x
- EV / EBIT
- 29.42x
- Market cap
- $11.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026